Publication:
Molecular analysis of OXA-48-producing Escherichia coli in Switzerland from 2019 to 2020.

cris.virtual.author-orcid0000-0001-5722-9445
cris.virtualsource.author-orcida124746e-28d0-4c6b-b224-aa11f4e7db36
datacite.rightsopen.access
dc.contributor.authorFindlay, Jacqueline
dc.contributor.authorPerreten, Vincent
dc.contributor.authorPoirel, Laurent
dc.contributor.authorNordmann, Patrice
dc.date.accessioned2025-01-08T21:23:02Z
dc.date.available2025-01-08T21:23:02Z
dc.date.issued2022-11
dc.description.abstractOXA-48-type ß-lactamases are the most prevalent carbapenemase-type in Enterobacterales in Switzerland, predominantly found in Escherichia coli and Klebsiella pneumoniae. Bacteria-producing OXA-48-type enzymes are endemic in some parts of the world, including Europe and North Africa, and are a frequent cause of nosocomial infections. Despite the emergence of numerous OXA-48-type variants, the original variant, OXA-48, remains the most prevalent in E. coli. This study describes the epidemiology of OXA-48-producing E. coli isolates submitted to the Swiss National Reference Center for Emerging Antibiotic Resistance (NARA) between January 2019 and December 2020.
dc.description.numberOfPages6
dc.description.sponsorshipInstitut für Veterinärbakteriologie (IVB)
dc.identifier.doi10.48350/173058
dc.identifier.pmid36103096
dc.identifier.publisherDOI10.1007/s10096-022-04493-6
dc.identifier.urihttps://boris-portal.unibe.ch/handle/20.500.12422/202074
dc.language.isoen
dc.publisherSpringer
dc.relation.ispartofEuropean journal of clinical microbiology & infectious diseases
dc.relation.issn0934-9723
dc.relation.organization3A1C87BE67364269B9F920339755C936
dc.relation.organizationDCD5A442C494E17DE0405C82790C4DE2
dc.relation.organizationDCD5A442C1CCE17DE0405C82790C4DE2
dc.relation.organizationDCD5A442C494E17DE0405C82790C4DE2
dc.subjectCarbapenemase Epidemiology Escherichia coli OXA-48 Plasmid
dc.subject.ddc500 - Science::570 - Life sciences; biology
dc.subject.ddc600 - Technology::630 - Agriculture
dc.titleMolecular analysis of OXA-48-producing Escherichia coli in Switzerland from 2019 to 2020.
dc.typearticle
dspace.entity.typePublication
dspace.file.typetext
oaire.citation.endPage1360
oaire.citation.issue11
oaire.citation.startPage1355
oaire.citation.volume41
oairecerif.author.affiliationInstitut für Veterinärbakteriologie (IVB)
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.date.licenseChanged2022-09-23 02:45:12
unibe.description.ispublishedpub
unibe.eprints.legacyId173058
unibe.journal.abbrevTitleEUR J CLIN MICROBIOL
unibe.refereedtrue
unibe.subtype.articlejournal

Files

Original bundle
Now showing 1 - 1 of 1
Name:
s10096-022-04493-6.pdf
Size:
1.11 MB
Format:
Adobe Portable Document Format
File Type:
text
License:
https://creativecommons.org/licenses/by/4.0
Content:
published

Collections